Table 4 Difference in clinical features between iC1 subtype and iC2 subtype for LUAD
Variables | iC1 (n = 183) | iC2 (n = 257) | P |
|---|---|---|---|
Age (median [IQR]) | 63.50 [58.00, 72.00] | 67.00 [59.00, 74.00] | 0.068 |
Gender (%) | |||
Female | 86 (47.0) | 149 (58.0) | 0.026* |
Male | 97 (53.0) | 108 (42.0) | |
Status (%) | |||
Dead | 97 (53.0) | 185 (72.0) | < 0.001*** |
Alive | 86 (47.0) | 72 (28.0) | |
Pathologic T (%) | |||
T1 | 53 (29.0) | 99 (38.5) | 0.293 |
T2 | 105 (57.4) | 126 (49.0) | |
T3 | 17 (9.3) | 22 (8.6) | |
T4 | 7 (3.8) | 9 (3.5) | |
Tx | 1 (0.5) | 1 (0.4) | |
Pathologic N (%) | |||
N0 | 103 (56.3) | 186 (72.7) | < 0.001*** |
N1 | 44 (24.0) | 36 (14.1) | |
N2 | 34 (18.6) | 28 (10.9) | |
N3 | 1 (0.5) | 0 (0.0) | |
NX | 1 (0.5) | 6 (2.3) | |
Pathologic M (%) | 0.251 | ||
M0 | 121 (66.5) | 157 (61.8) | |
M1 | 10 (5.5) | 9 (3.5) | |
Mx | 51 (28.0) | 88 (34.6) | |
Tumor stage (%) | < 0.001*** | ||
I | 79 (43.4) | 159 (62.8) | |
II | 57 (31.3) | 51 (20.2) | |
III | 36 (19.8) | 34 (13.4) | |
IV | 10 (5.5) | 9 (3.6) | |